The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 983 | 35,000 | SH | DFND | 35,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 1,102 | 12,000 | SH | DFND | 12,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 1,322 | 18,000 | SH | DFND | 18,000 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 1,175 | 390,307 | SH | DFND | 390,307 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 1,359 | 28,000 | SH | DFND | 28,000 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 486 | 148,092 | SH | DFND | 148,092 | 0 | 0 | ||
| LIVONGO HEALTH INC | COM | 539183103 | 45,983 | 2,636,640 | SH | DFND | 2,636,640 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 1,171 | 22,464 | SH | DFND | 22,464 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 35,524 | 2,990,211 | SH | DFND | 2,990,211 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 2,356 | 727,260 | SH | DFND | 727,260 | 0 | 0 | ||
| PRECISION BIOSCIENCES INC | COM | 74019P108 | 9,093 | 1,083,786 | SH | DFND | 1,083,786 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 1,027 | 24,000 | SH | DFND | 24,000 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 903214104 | 1,139 | 790,805 | SH | DFND | 790,805 | 0 | 0 | ||